MedPath

Biomarkers of exposition_Uchuva Dorada

Not Applicable
Completed
Conditions
ot applicable. The study seeks to identify biomarkers associated with the acute and chronic consumption of cape gooseberry, and the impact of this consumption on the composition of the intestinal microbiota.
Healthy Volunteers
Biomarkers
Registration Number
RPCEC00000268
Lead Sponsor
CORPOICA
Brief Summary

See attachment

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Male
Target Recruitment
20
Inclusion Criteria

1.Male volunteers
2.With age =20 and =50 y
3.BMI between 18.8 Kg / mt2 and 24.9 Kg / mt2,
4.Consumers of cape gooseberries and citrus fruits
5.Non-smokers
6.Non- high performance athlete (subjects with a sedentary physical activity, mild or moderate, without exceeding 10 hours per week of training).
7.No history and/or diagnosis of chronic diseases (cardiovascular, hypertension, congestive heart failure, stroke, arrhythmias, dyslipidemia, diabetes mellitus, cancer, chronic renal failure, liver disorders, hypothyroidism, insomnia, duodenal ulcer, gastritis, disorders of malignancy absorption, Alzheimer's, Parkinson's or any other neurodegenerative disease that prevents an adequate collection of information, cancer, Crohn's disease, ulcerative colitis, short bowel syndrome or celiac disease, dysautonomies, sleep disorders and psychiatric disorders)
8.Not currently consuming medication (lipid-lowering drugs, antioxidant supplements, natural products, supplements or dietary supplements, multivitamins, antiepileptics, steroidal anti-inflammatories, hypnotic drugs)
9.Without antibiotic or antiparasitic use in the last three months.
10.Volunteers should have a work schedule between 7.00 a.m. and 6.00 p.m. from Monday to Friday and not having to leave the workplace during the time the study lasts.

Exclusion Criteria

1. Women.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.